Immunotherapy efficacy of strong positive PD-L1 expression non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis.

被引：0
|
作者：
Lu, Hongmin
Cui, Longgang
Bai, Yuezong
Zhang, Yuzi
Zhao, Zhengyi
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Renji Hosp, Shanghai, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21701
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pathological response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer (NSCLC): A systematic review and meta-analysis.
    Syaj, Sebawe
    Akhdar, Marah
    Ababneh, Obada Ehab
    Hamouri, Shadi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.
    Wao H.
    Mhaskar R.
    Kumar A.
    Miladinovic B.
    Djulbegovic B.
    Systematic Reviews, 2 (1) : 10
  • [33] Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
    Puig Sanchez, Francisco Guillermo
    Roman Rodriguez, Lucas
    Barca Hernando, Maria
    Marquez Martin, Eduardo
    Romero Romero, Beatriz
    Martin Juan, Jose
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [34] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [35] Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Acheampong, Emmanuel
    Abed, Afaf
    Morici, Michael
    Bowyer, Samantha
    Amanuel, Benhur
    Lin, Weitao
    Millward, Michael
    S. Gray, Elin
    CELLS, 2020, 9 (11) : 1 - 24
  • [36] PD-L1 heterogeneity in patients with non-small cell lung cancer
    Wei, Zhigang
    Fan, Linlin
    Yang, Xia
    Li, Jie
    Zhan, Xuemei
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E268 - E274
  • [37] PD-L1 immunohistochemistry in patients with non-small cell lung cancer
    Jotatsu, Takanobu
    Oda, Keishi
    Yatera, Kazuhiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2127 - S2129
  • [38] Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
    Zeng, Tian
    Qin, Qin
    Bian, Zhiheng
    Li, Jianjun
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 4194 - 4201
  • [39] Efficacy of Chemo-Radiotherapy (CRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression
    Adam, Julien
    Boros, Angela
    Lacas, Benjamin
    Lacroix, Ludovic
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    Besse, Benjamin
    Le Pechoux, Cecile
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S244 - S244
  • [40] Genomic correlates of PD-L1 expression are associated with response to immunotherapy in non-small cell lung cancer
    Spurr, Liam F.
    Lamberti, Giuseppe
    Li, Yvonne Y.
    Ricciuti, Biagio
    Recondo, Gonzalo
    Umeton, Renato
    Sholl, Lynette M.
    Meyerson, Matthew L.
    Cherniack, Andrew D.
    Awad, Mark M.
    CANCER RESEARCH, 2020, 80 (16)
12345